Chronic stress and Parkinson's disease

CNS Neuroscience and Therapeutics

Volumn 20, Issue 1, 2014, Pages 1-2

  Hou, Gonglin ^a   Tian, Rui ^a   Li, Jiang ^b   Yuan, Ti Fei ^a,c  

^a ZHEJIANG SCI TECH UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c NANJING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; CHRONIC STRESS; DEPRESSION; DOPAMINERGIC NERVE CELL; EDITORIAL; HUMAN; MOOD DISORDER; NONHUMAN; PARKINSON DISEASE;

ANIMALS; BRAIN; CHRONIC DISEASE; HUMANS; PARKINSON DISEASE; STRESS, PSYCHOLOGICAL;

EID: 84890516170     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12209     Document Type: Editorial

References (10)

1. Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR. Higher incidence of depression preceding the onset of Parkinson's disease: A register study. Mov Disord 2003;18:414-418.
2. Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128:1314-1322.
3. Lieberman A. Depression in Parkinson's disease - a review. Acta Neurol Scand 2006;113:1-8.
4. Hemmerle AM, Dickerson JW, Herman JP, Seroogy KB. Stress exacerbates experimental Parkinson's disease. Mol Psychiatry 2013; doi:10.1038/mp.2013.108. [Epub ahead of print].
5. Palhagen SE, Carlsson M, Curman E, Walinder J, Granerus AK. Depressive illness in Parkinson's disease-indication of a more advanced and widespread neurodegenerative process? Acta Neurol Scand 2008;117:295-304.
6. Rommelfanger KS, Edwards GL, Freeman KG, Liles LC, Miller GW, Weinshenker D. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proc Natl Acad Sci U S A 2007;104:13804-13809.
7. Ros-Bernal F, Hunot S, Herrero MT, et al. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci U S A 2011;108:6632-6637.
8. Piazza PV, Le Moal ML. Pathophysiological basis of vulnerability to drug abuse: Role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 1996;36:359-378.
9. Chaudhury D, Walsh JJ, Friedman AK, et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 2013;493:532-536.
10. Paumier KL, Siderowf AD, Auinger P, et al. Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease. Mov Disord 2012;27:880-887.